LOGIN TO YOUR ACCOUNT

Username
Password
Remember Me
Or use your Academic/Social account:

CREATE AN ACCOUNT

Or use your Academic/Social account:

Congratulations!

You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.

Important!

Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message

CREATE AN ACCOUNT

Name:
Username:
Password:
Verify Password:
E-mail:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Zeng, C; Guo, XY; Long, JR; Kuchenbaecker, KB; Droit, A; Michailidou, K; Ghoussaini, M; Kar, S; Freeman, A; Hopper, JL; Milne, RL; Bolla, MK; Wang, Q; Dennis, J; Agata, S; Ahmed, S; Aittomaki, K; Andrulis, IL; Anton-Culver, H; Antonenkova, NN; Arason, A; Arndt, V; Arun, BK; Arver, B; Bacot, F; Barrowdale, D; Baynes, C; Beeghly-Fadiel, A; Benitez, J; Bermisheva, M ... view all 237 authors View less authors (2016)
Publisher: eScholarship, University of California
Languages: English
Types: Article
Subjects: PTHLH, BRAC1 mutation carriers; Breast cancer; CCDC91; Fine-scale mapping; Genetic risk factor; PTHLH, LOCALIZATION, BRAC1 mutation carriers, Research Article, Cancer och onkologi, GENETIC MODIFIERS, Oncology, Cancer Research, UOWSAT, 3111 Biomedicine, METASTASIS, PTHLH-CCDC91, OVARIAN-CANCER, HORMONE-RELATED PROTEIN, Medizinische Fakultät, 3122 Cancers, EXPRESSION, Biology and Life Sciences, ENHANCERS, SUSCEPTIBILITY LOCI, CCDC91, Breast cancer, -, Genetic risk factor, Cancer and Oncology, Fine-scale mapping, Medizin, Medical Genetics, Medicinsk genetik, /dk/atira/pure/subjectarea/asjc/2700/2730, Journal Article, BRCA2 MUTATION CARRIERS, /dk/atira/pure/subjectarea/asjc/1300/1306, Medicine and Health Sciences, GENOME-WIDE ASSOCIATION
ddc: ddc:610
Background Multiple recent genome-wide association studies (GWAS) have identified a single nucleotide polymorphism (SNP), rs10771399, at 12p11 that is associated with breast cancer risk. Method We performed a fine-scale mapping study of a 700 kb region including 441 genotyped and more than 1300 imputed genetic variants in 48,155 cases and 43,612 controls of European descent, 6269 cases and 6624 controls of East Asian descent and 1116 cases and 932 controls of African descent in the Breast Cancer Association Consortium (BCAC; http://bcac.ccge.medschl.cam.ac.uk/), and in 15,252 BRCA1 mutation carriers in the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). Stepwise regression analyses were performed to identify independent association signals. Data from the Encyclopedia of DNA Elements project (ENCODE) and the Cancer Genome Atlas (TCGA) were used for functional annotation. Results Analysis of data from European descendants found evidence for four independent association signals at 12p11, represented by rs7297051 (odds ratio (OR) = 1.09, 95 % confidence interval (CI) = 1.06–1.12; P = 3 × 10$^{-9}$), rs805510 (OR = 1.08, 95 % CI = 1.04–1.12, P = 2 × 10$^{-5}$), and rs1871152 (OR = 1.04, 95 % CI = 1.02–1.06; P = 2 × 10$^{-4}$) identified in the general populations, and rs113824616 (P = 7 × 10$^{-5}$) identified in the meta-analysis of BCAC ER-negative cases and BRCA1 mutation carriers. SNPs rs7297051, rs805510 and rs113824616 were also associated with breast cancer risk at P < 0.05 in East Asians, but none of the associations were statistically significant in African descendants. Multiple candidate functional variants are located in putative enhancer sequences. Chromatin interaction data suggested that PTHLH was the likely target gene of these enhancers. Of the six variants with the strongest evidence of potential functionality, rs11049453 was statistically significantly associated with the expression of PTHLH and its nearby gene CCDC91 at P < 0.05. Conclusion This study identified four independent association signals at 12p11 and revealed potentially functional variants, providing additional insights into the underlying biological mechanism(s) for the association observed between variants at 12p11 and breast cancer risk. UK funding includes Cancer Research UK and NIH. This is the final version of the article. It first appeared from BioMed Central via http://dx.doi.org/10.1186/s13058-016-0718-0

Share - Bookmark

Funded by projects

Cite this article